glp 1 reduces inflammation GLP-1 drugs calm beyond diabetes and weight loss Anti-inflammatory role of glucagon-like peptide

Interestingly, glucagon-like peptide-1 receptor agonists (GLP-1RAs), used in the treatment of T2DM and obesity, are known to show pro-cognitive and neuroprotective properties, and exert modulatory effects on immune, endocrine and metabolic processes in the central nervous system

Semaglutide 24 Mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): A randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial

Back De Herder, W, Klppel, G (28 July 2023) 'One hundred years after the discovery of insulin and glucagon: the history of tumors and hyperplasias that hypersecrete these hormones', Endocrine-Related Cancer , 30/9

It is important to understand that tirzepatide is not an immediate solution

While digestive enzymes while on GLP-1 therapy are sometimes considered, understanding the evidence, safety considerations, and proven management strategies is essential before adding supplements to your treatment regimen